Beyond Spring Pharma Stock
Nevertheless, pantginis rates beyondspring a. (bysi) stock news and headlines to help you in your trading and investing decisions. Why Beyondspring Is Plunging Today The Motley Fool Revenue forecast of us$912.7k unchanged since last update. Beyond spring pharma stock . Shares of beyondspring ( nasdaq:bysi) soared on wednesday after the pharmaceutical company released promising clinical trial results for. Learn more on how bysi compares to other companies It's therefore worth looking at beyondspring's earnings history below. In china, we own a 57.97% interest in our chinese subsidiary, dalian wanchunbulin pharmaceuticals ltd. A stock market crash can be a harrowing experience to endure, and watching the value of your portfolio fall can cause temptations to sell. The closing price, day’s high, day’s low, and day’s volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. B...